Therefore, in the effect of miR-27b acting on EMT/PI3K/AKT pathway on diffuse large B-cell lymphoma, crizotinib can achieve the same effect as miR-27b NC to activate the expression of miR-27b to achieve the inhibition effect of EMT. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.